2Fung SK,Lok AS.Rruginside:Nucleoside and nucleoside analogy inhibitors for hepatitis B[J].Nat Clin Part Gastroenterol Hepatol,2004,1 (2):90-97.
3Hui CK,Lau GK.Advance in immunodulating therapy of HBV infection[J].Int J Med Sci,2005,2(1):24-29.
4Macellin P,Chang TT,Lim S,et al.Long term efficacy and safety of adefovir dipivoxil 10 mg in HBeAg+ chronic hepatitis B patients:increasing serologic,virologic and biochemical response over time[J].Hepatology,2004,40(4,suppl):655A.
5Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Longterm therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitisB[J].N Engl J Med,2005,352(26):2673-2681.
6Perrillo R,Hann HW,Mutimer D,et al.Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus[J].Gastroenterology,2004,126 (1):81-90.
7Locarnini S,Shaw T,Sozzi T,et al.HBV mutants associated with clinical resistance to adefovir dipivoxil display only small decreases in antiviral sensitivity in vitro[J].Hepatology,2004,40 (4 suppl):244A.
